Avian influenza is continuing to plague poultry and dairy farming operations, and with the virus spreading across the country ...

Q&A: From people avoiding wild birds to farmers protecting their animals, Kent State epidemiologist Dr. Tara Smith shares ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

A Nevada dairy worker who initially tested positive for bird flu is currently experiencing mild symptoms, including "pink eye ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

ICMR seeks collaboration for H5N1 vaccine development to combat bird flu threat in India, emphasizing preparedness and public ...

Robert F. Kennedy Jr., told senators Thursday he would support the development and distribution of avian flu vaccines for ...

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug NV-387, a drug that the Bird Flu ...

Last year, Moderna completed a Phase I/II clinical trial of an investigational influenza vaccine called mRNA-1018, which was tested against H5 and H7 bird flu subtypes. The company said in a Jan ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

A Moderna spokesperson told MassLive the company is preparing to advance its bird flu vaccine (mRNA-1018) into a phase 3 study, “based on the positive preliminary data from the Phase 1/2 study.” ...